PSMB2 and RPL32 are suitable denominators to normalize gene expression profiles in bronchoalveolar cells-2

Zed to 1); the whiskers on each box represent the SD values. For details see Methods section Gene expression measurements by qRT-PCR. *< 0.05.<p><b>Copyright information:</b></p><p>Taken from "PSMB2 and RPL32 are suitable denominators to normalize gene expression profiles in bronchoalveolar cells"</p><p>http://www.biomedcentral.com/1471-2199/9/69</p><p>BMC Molecular Biology 2008;9():69-69.</p><p>Published online 31 Jul 2008</p><p>PMCID:PMC2529339.</p><p></p

PSMB2 and RPL32 are suitable denominators to normalize gene expression profiles in bronchoalveolar cells-1

Ents with involvement of parenchyma: CXR stages II/III)-Mean(patients without involvement of parenchyma: CXR stage I), Mean(Löfgren's syndrome patients)-Mean(non-Löfgren's syndrome patients), Mean(multi-organ involvement)-Mean(involvement of lung only), Mean(smokers)-Mean(non-smokers), Mean(males)-Mean(females), and Mean(pathological BAL cell count)-Mean(normal BAL cell count) for macrophages, lymphocytes, neutrophils and eosinophils. For more details see the legend to Fig. 2.<p><b>Copyright information:</b></p><p>Taken from "PSMB2 and RPL32 are suitable denominators to normalize gene expression profiles in bronchoalveolar cells"</p><p>http://www.biomedcentral.com/1471-2199/9/69</p><p>BMC Molecular Biology 2008;9():69-69.</p><p>Published online 31 Jul 2008</p><p>PMCID:PMC2529339.</p><p></p

Contribution to the misclassification of an individual clinical component interpreted within the GOLD 2011 classification matrix.

<p>The percentage indicates relative frequency of misclassified cases attributable to a given clinical component. A sole effect is responsible for misclassified cases due to an obvious error in interpretation of one specific primary clinical parameter. The combined effect is responsible for misclassified cases due to an obvious error in interpreting both clinical criteria on the same axis (mMRC dyspnea scale and CAT respective bronchial obstruction and number of COPD exacerbations/year). <i>Statistical probabilities were calculated of pair-wise contrasts as follows; mMRC dyspnea scale vs. CAT (p>0.05), mMRC dyspnea scale vs. bronchial obstruction based on post bronchodilator FEV1 (p<0.0001), mMRC dyspnea scale vs. number of exacerbations/year (p<0.0001), CAT vs. bronchial obstruction (p<0.0001), CAT vs. number of exacerbations/year (p<0.0001), bronchial obstruction vs. number of exacerbations/year (p<0.0001).</i></p

PSMB2 and RPL32 are suitable denominators to normalize gene expression profiles in bronchoalveolar cells-0

Ker box plots; the box represents the 25th–75th percentiles, the median is indicated by a bar across the box, the whiskers on each box represent the minimum and maximum values.<p><b>Copyright information:</b></p><p>Taken from "PSMB2 and RPL32 are suitable denominators to normalize gene expression profiles in bronchoalveolar cells"</p><p>http://www.biomedcentral.com/1471-2199/9/69</p><p>BMC Molecular Biology 2008;9():69-69.</p><p>Published online 31 Jul 2008</p><p>PMCID:PMC2529339.</p><p></p

Effect of number of COPD patients seen in a month on a discrepancy between subjectively classified patients into GOLD 2011 groups and classification achieved by objective assessment using software.

<p>Effect of number of COPD patients seen in a month on a discrepancy between subjectively classified patients into GOLD 2011 groups and classification achieved by objective assessment using software.</p

Use of ICS in monotherapy or combination therapy.

<p>Use of ICS in monotherapy or combination therapy.</p

Original version of the Czech Republic map in SVG format.

<p>Original version of the Czech Republic map in SVG format.</p

Numbers of COPD specialists involved in the research by country regions of the Czech Republic.

<p>Numbers of COPD specialists involved in the research by country regions of the Czech Republic.</p